John J. Harrington, Chief Scientific Officer at ATHERSYS, INC / NEW (ATHX), sold 24,875 shares at $1.23 ($30K) on 2015-06-19, disclosed to the SEC on 2015-06-19.
Scheduled sale ($30k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 1,106 | $1K | 4.5% |
| 2 | $1.21 | 15,619 | $19K | 62.4% |
| 3 | $1.23 | 4,075 | $5K | 16.6% |
| 4 | $1.23 | 4,075 | $5K | 16.6% |
| Total | $1.22 avg | 24,875 | $30K | 100% |
| Filing → |
| ATHX | SELL | 2021-06-08 | $47K | — | Filing → |
| ATHX | SELL | 2021-06-02 | $36K | — | Filing → |
| ATHX | SELL | 2021-03-17 | $20K | — | Filing → |